Abstract: The disclosure provides an improved antenna that can be employed on wireless communications structures, such as cell towers and vehicles. The disclosed antenna, a miniature technology antenna (MTA), can be a directional antenna that is used for communicating within a defined sector and can be used for communicating with satellites. The disclosure provides an antenna for wireless communications. In one example, the antenna includes: (1) a substantially spherical Luneburg lens, and (2) signal conveyors configured to communicate with corresponding orbiting antennas using radio frequency signals passing though the Luneburg lens. A communications system is also disclosed. In one example, the communications system include: (1) radio equipment, and (2) one or more of the antennas.

Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.

Abstract: The disclosure provides a wireless communications systems that uses a polybeam geometry. A polybeam communications network, a polybeam antenna, a method of communicating are disclosed. In one example, the polybeam communications network includes: (1) a first communications structure, (2) first transceivers, and (3) a first polybeam antenna attached to the first communications structure that transmits first communication beams driven by corresponding ones of the first transceivers, having arcs of less than twenty degrees each and defining overlapping territories of coverage.

Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.

Abstract: A rectal injection device configured to inject a liquid into the tissues around the internal anal sphincter of a rectum. The rectal injection device comprises: i) an elongated tube having a distal end and a proximal end; ii) a rounded head coupled to the distal end of the elongated tube; iii) a needle extending from the proximal end of the elongated tube into the rounded head, wherein a tip of the needle is aligned with a hole in the rounded head; and iv) an actuator mechanism configured to move the needle to a deployed position in which the tip of the needle extends through the hole and into the anal tissues and to move the needle to a retracted position in which the tip of the needle is withdrawn within the rounded head.

Abstract: The present disclosure provides ophthalmic compositions containing resveratrol. Also provided are methods of using ophthalmic resveratrol compositions to treat acute ocular pain, chronic ocular pain, dry eye disease, and/or photophobia.

Abstract: A rectal injection device and a method of operating a rectal injection device. In one embodiment, the device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two needles coupled to the head and configured to move relative thereto between a retracted position and a deployed position and (4) a pullrod coupling the trigger and the needles and configured to cause the needles to move.

Abstract: A rectal band ligation device and a method of operating the band ligation device. In one embodiment, the band ligation device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two openings in the head, (4) hollow pistons located in the openings and configured to move relative thereto between an extended position in which ends of the pistons are exposed through the openings and a retracted position, gaps between corresponding openings and hollow pistons being less than cross-sectional widths of elastic members stretched around the ends and (5) an actuating rod coupling the trigger and the pistons and configured to cause the pistons to move from the extended position to the retracted position.

Abstract: A topical medication including a therapeutically effective amount of an AMPK (adenosine monophosphate-activated protein kinase) agonist for use in the treatment of one or more the human or animal medical conditions. The medical conditions include, but are not limited to: shingles (herpes zoster), post-herpetic neuralgia (PHN), gout, migraine, trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), diabetic neuropathy, peripheral neuropathy, rheumatoid arthritis, insect-related wheals, urushiol-related rash, psoriasis, herpes simplex, atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, neurotrophic ulcers, first- and second-degree burns (e.g., sunburn and chemical), fibromyalgia, rubeola, and acne. Also disclosed are a method of employing the composition and a wound dressing incorporating a therapeutically effective amount of an AMPK agonist in combination with an antimicrobial agent.

Abstract: A rectal band ligation device and a method of operating the band ligation device. In one embodiment, the band ligation device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two openings in the head, (4) hollow pistons located in the openings and configured to move relative thereto between an extended position in which ends of the pistons are exposed through the openings and a retracted position, gaps between corresponding openings and hollow pistons being less than cross-sectional widths of elastic members stretched around the ends and (5) an actuating rod coupling the trigger and the pistons and configured to cause the pistons to move from the extended position to the retracted position.

Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.

Abstract: A topical medication including a therapeutically effective amount of an AMPK (adenosine monophosphate-activated protein kinase) agonist for use in the treatment of one or more the human or animal medical conditions. The medical conditions include, but are not limited to: shingles (herpes zoster), post-herpetic neuralgia (PHN), gout, migraine, trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), diabetic neuropathy, peripheral neuropathy, rheumatoid arthritis, insect-related wheals, urushiol-related rash, psoriasis, herpes simplex, atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, neurotrophic ulcers, first- and second-degree burns (e.g., sunburn and chemical), fibromyalgia, rubeola, and acne. Also disclosed are a method of employing the composition and a wound dressing incorporating a therapeutically effective amount of an AMPK agonist in combination with an antimicrobial agent.

Abstract: A rectal band ligation device and a method of operating the band ligation device. In one embodiment, the band ligation device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two openings in the head, (4) hollow pistons located in the openings and configured to move relative thereto between an extended position in which ends of the pistons are exposed through the openings and a retracted position, gaps between corresponding openings and hollow pistons being less than cross-sectional widths of elastic members stretched around the ends and (5) an actuating rod coupling the trigger and the pistons and configured to cause the pistons to move from the extended position to the retracted position.

Abstract: A rectal injection device configured to inject a liquid into the tissues around the internal anal sphincter of a rectum. The rectal injection device comprises: i) an elongated tube having a distal end and a proximal end; ii) a rounded head coupled to the distal end of the elongated tube; iii) a needle extending from the proximal end of the elongated tube into the rounded head, wherein a tip of the needle is aligned with a hole in the rounded head; and iv) an actuator mechanism configured to move the needle to a deployed position in which the tip of the needle extends through the hole and into the anal tissues and to move the needle to a retracted position in which the tip of the needle is withdrawn within the rounded head.

Abstract: A rectal injection device and a method of operating a rectal injection device. In one embodiment, the device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two needles coupled to the head and configured to move relative thereto between a retracted position and a deployed position and (4) a pullrod coupling the trigger and the needles and configured to cause the needles to move.

Abstract: A rectal injection device and a method of operating a rectal injection device. In one embodiment, the device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two needles coupled to the head and configured to move relative thereto between a retracted position and a deployed position and (4) a pullrod coupling the trigger and the needles and configured to cause the needles to move.

Abstract: A rectal injection device and a method of operating a rectal injection device. In one embodiment, the device includes: (1) a handle having a trigger associated therewith, (2) an extension tube extending from the handle and terminating in a head, (3) at least two needles coupled to the head and configured to move relative thereto between a retracted position and a deployed position and (4) a pullrod coupling the trigger and the needles and configured to cause the needles to move.

Abstract: A pen drive and a method of operating the same. In one embodiment, the pen drive has a body and includes: (1) a nonvolatile main memory, (2) a Universal Serial Bus (USB) port coupled to the nonvolatile main memory and including a USB plug, (3) a power source, (4) a USB host controller coupled to the nonvolatile main memory and powered by the power source, (5) a USB receptacle coupled to the USB host controller and (6) a processor coupled to the USB host controller and the nonvolatile main memory and configured to initiate a transfer of at least one user file therebetween.

Abstract: A USB mass storage device interconnect module and a method of operating the same to effect an automatic transfer of at least one file between two USB mass storage devices. In one embodiment, the interconnect module includes: (1) a body, (2) first and second USB receptacles recessed into the body, (3) a power source, (4) a USB host controller contained within the body, coupled to the first and second USB receptacles and powered by the power source and (5) a processor contained within the body, coupled to the USB host controller, powered by the power source and configured to initiate an automatic transfer of at least one user file between the first and second USB mass storage devices when the first and second USB mass storage devices are coupled to the first and second USB receptacles.

Abstract: Systems, methods, infrastructures and electronic mail (e-mail) messages are set forth that allow e-mail to be converted to physical mail form and physically mailed to recipients. The e-mail messages themselves carry the data sufficient to identify the physical mailing address of their intended recipients. In one embodiment, an e-mail message transmissible through a computer network and forwardable via a physical mail distribution system includes: (1) a body and (2) a header having physical mailing address data located in an address therein that is employable to forward information contained in the body to a physical mailing address in physical mail form. In embodiments wherein sufficient data regarding the physical mailing address are contained in an e-mail address, various systems and methods are set forth that generate e-mail addresses containing the data. Various systems and methods are also described that convert the e-mail to physical form for physical mailing.